Takeda officer granted 27,586 RSUs

Pignagnoli Agosti Marcello reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Pignagnoli Agosti Marcello reported acquisition or exercise transactions in this Form 4 filing.

TAKEDA PHARMACEUTICAL CO LTD reported that officer Marcello Pignagnoli Agosti received an equity award in the form of 27,586 American Depositary Shares through restricted stock units. This award was granted at no cash cost to him and increases his directly held stake to 199,934 ADS.

The restricted stock units vest in three equal annual installments beginning on July 1, 2027, meaning the shares will be delivered over time as long-term compensation. This is a routine, compensation-related grant rather than an open-market purchase or sale.

Insider Trade Summary

Grant/Award: 27,586 shares

Grant/Award 1 txn

Insider Pignagnoli Agosti Marcello

Role Head, Strat. & Port. Dev.

Type	Security	Shares	Price	Value
Grant/Award	American Depositary Shares	27,586	$0.00	$0.00

Holdings After Transaction: American Depositary Shares — 199,934 shares (Direct)

Footnotes (1)

1. F1. Represents an award of restricted stock units (RSUs). Each RSU represents a contingent right to receive one American Depositary Share. The RSUs vest in three equal annual installments beginning on July 1, 2027.

Key Figures

RSU grant size: 27,586 ADS-equivalent units Grant price: $0.00 per ADS Holdings after grant: 199,934 ADS +2 more

5 metrics

RSU grant size 27,586 ADS-equivalent units Restricted stock unit award to officer

Grant price $0.00 per ADS Reported transaction price per share

Holdings after grant 199,934 ADS Total direct holdings following transaction

First vesting date July 1, 2027 Start of three annual vesting installments

Vesting structure Three equal annual installments RSU vesting schedule

Key Terms

restricted stock units (RSUs), American Depositary Shares, vest in three equal annual installments, grant, award, or other acquisition

4 terms

restricted stock units (RSUs) financial

"Represents an award of restricted stock units (RSUs). Each RSU represents a contingent right to receive one American Depositary Share."

Restricted stock units (RSUs) are a type of company promise to give employees shares of stock in the future, usually after certain conditions like working for a set time. They are like a gift promised today that you receive later, which can become valuable if the company's stock price goes up. RSUs matter because they are a way companies reward employees and can be a significant part of compensation.

American Depositary Shares financial

"Each RSU represents a contingent right to receive one American Depositary Share."

American depositary shares (ADSs) are a way for investors in the United States to buy shares of foreign companies without dealing with international markets directly. They represent ownership in a foreign company's stock and are traded on U.S. stock exchanges, making it easier for American investors to buy, sell, and own parts of companies from around the world.

vest in three equal annual installments financial

"The RSUs vest in three equal annual installments beginning on July 1, 2027."

grant, award, or other acquisition financial

"transaction_code_description": "Grant, award, or other acquisition""

FAQ

What insider transaction did TAK (Takeda Pharmaceutical) report in this Form 4?

Takeda reported that officer Marcello Pignagnoli Agosti received an award of 27,586 restricted stock units, each tied to one American Depositary Share. The grant was recorded at a price of $0.00 per share as part of his equity compensation.

How many Takeda (TAK) shares does the insider hold after this RSU grant?

After the restricted stock unit grant, Marcello Pignagnoli Agosti is reported as directly holding 199,934 American Depositary Shares. This total includes the newly awarded 27,586 units, which are scheduled to vest over time according to the disclosed vesting schedule.

What is the vesting schedule for the new Takeda (TAK) RSU award?

The restricted stock units vest in three equal annual installments beginning on July 1, 2027. Each installment represents one-third of the 27,586 units, with each vested unit delivering one American Depositary Share to the reporting officer upon vesting.

Did the Takeda (TAK) insider buy or sell shares on the open market?

The filing shows no open-market buying or selling. Instead, Marcello Pignagnoli Agosti received 27,586 American Depositary Shares through a grant of restricted stock units, recorded at $0.00 per share as part of his compensation rather than a market transaction.

What type of security was granted in this Takeda (TAK) Form 4 filing?

The award consists of restricted stock units, with each RSU representing a contingent right to receive one American Depositary Share of Takeda. These units convert into actual ADS over three years, subject to the vesting schedule starting July 1, 2027.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/06/2026 - 06:04 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Pignagnoli Agosti Marcello

(Last) (First) (Middle)

300 MASSACHUSETTS AVE.

(Street)

CAMBRIDGE MASSACHUSETTS 02139

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
TAKEDA PHARMACEUTICAL CO LTD [ TAK ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Head, Strat. & Port. Dev.

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
American Depositary Shares	07/01/2026		A(1)		27,586	A	$0	199,934	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents an award of restricted stock units (RSUs). Each RSU represents a contingent right to receive one American Depositary Share. The RSUs vest in three equal annual installments beginning on July 1, 2027.

Remarks:

	/s/ Kate Huleatt, by power of attorney, for Marcello P. Agosti	07/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)